Seattle-based biotech Vedana Therapeutics launched out of stealth Wednesday with a $46 million Series A round.
A James Beard-nominated restaurateur finally brings his long-delayed Chinatown International District project to life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results